Gordon Lab / CV & Publications

Curriculum Vitae - Mae Gordon, Ph.D.

Address

Office: Department of Ophthalmology & Visual Sciences
Washington University School of Medicine
660 South Euclid Avenue - Box 8096
St. Louis, MO  63110-1093
(314) 362-3716

e-mail: mae@vrcc.wustl.edu

Present Positions

Professor
Division of Biostatistics
Washington University School of Medicine
St. Louis, MO  63110-1093

Professor
Department of Ophthalmology & Visual Sciences
Washington University School of Medicine
St. Louis, MO  63110-1093

Education

1966	BA - Portland State University         Portland, Oregon
1969	MS (Sociology) - University of Wisconsin-Madison         Madison, Wisconsin
1979	PhD (Sociology, Psychometrics) - University of Wisconsin-Madison         Madison, Wisconsin
1975	University of Michigan         Institute for Survey Research         Logistic Regression Analysis
1972-79	Instructor         Department of Sociology         University of Missouri-St. Louis Research Instructor Department of Ophthalmology & Visual Sciences Washington University School of Medicine
1985-87	Research Instructor Division of Biostatistics Washington University School of Medicine
1988-92	Research Assistant Professor         Department of Ophthalmology & Visual Sciences         Division of Biostatistics         Washington University School of Medicine Department of Ophthalmology & Visual Sciences         Division of Biostatistics         Washington University School of Medicine
1992-2000	Associate Professor
2000-Present	Professor         Department of Ophthalmology & Visual Sciences         Division of Biostatistics         Washington University School of Medicine

University Appointments and Committees

1993-Present	Residency Selection Committee, Department of Ophthalmology and Visual Sciences
2005-Present	Human Subject Research Quality Assurance/Quality Improvement Program
2005-Present	Executive Committee of the K12 Multidisciplinary Clinical Research Career Development Program (Fraser, PI)

Honors and Awards

1962	Japanese-American Citizens League Award
1962	State of Oregon Scholarship Award
1964	Fellowship, National Training Laboratory Workshop
1965	John Francis Cramer Student Activities Award
1965	Outstanding Student Award, Portland State University U.S. Representative to Japanese-American Student         Conference, Tokyo, Japan Student Body Vice President, Portland State University
1966	Outstanding Sociology Student Award, Portland State         University
1967-68	NIMH Fellowship, University of Wisconsin         Dr. Edgar Borgatta, Social Science Research Institute in         Research Methodology
1971	Doctoral Research Award, National Academy of Science
2003	Association of International Glaucoma Societies Award - award to the Ocular Hypertension Treatment Study for "daring, breakthrough, creative, original research in glaucoma. New York Academy of Medicine - Lewis Rudin Glaucoma Prize - awarded for most outstanding glaucoma research published during 2022. Editorial Responsibilities         American Journal of Ophthalmology         Archives of Ophthalmology         Controlled Clinical Trials

Professional Societies and Organizations

1980-Present	Member, Association for Research in Vision and Ophthalmology
1982-89	Statistical consultant for multi-center clinical trials, Vision Research Review Committee, NEI
1982-Present	Member, Society for Controlled Clinical Trials
1985-Present	Member, American Statistical Association
1986-90	Chairperson, Data Safety and Monitoring Committee, Prism Adaptation Randomized Clinical Trial, NEI
1987-91	Statistical Consultant, Data Safety and Monitoring Committee, Retinitis Pigmentosa Randomized Clinical Trial, NEI
1989-Present	Executive Committee, Collaborative Longitudinal Evaluation in Keratoconus Study, NEI
1990-Present	Director, Coordinating Center for Multi-Center Ocular Hypertension Treatment Study, NEI
1990-Present	Executive Committee, Multi-Center Ocular Hypertension Treatment Study
1991-Present	Statistical consultant for multi-center clinical trials, Vision Research Review Committee, NEI
1991-Present	Association for Research in Vision and Ophthalmology (ARVO), Strategic Planning Committee
2005-Present	Society for Clinical Trials (SCT), Fellows Committee Consulting Relationships and Board Memberships
1982-89	Statistical consultant for multi-center clinical trials, Vision Research Review Committee, NEI
1986-90	Chairperson, Data and Safety Monitoring Committee, Prism Adaptation Randomized Clinical Trial, NEI
1987-91	Data and Safety Monitoring Committee, Statistical Consultant, Retinitis Pigmentosa Randomized Clinical Trial, NEI
1989-Present	Executive Committee, Contact Lens Evaluation in Keratoconus Multi-Center Study, NEI Division of Biostatistics, Statistics Course
1990	Statistical consultant, NIH Consensus Conference on the Clinical Use of Botulinum Toxin.
1990-Present	Executive Committee, Ocular Hypertension Treatment Study, NEI Director, Coordinating Center for Multi-Center Ocular Hypertension Treatment Study, NEI Department of Psychiatry, Psychiatric Epidemiology Training Program Master's Thesis Committee. Mentor for Raymond Wee, Doris Duke Clinical Research Fellowship Program, "Sleep Disturbances in the Blind." Thesis Advisor. AOS Thesis, "Risk of a New Retinal Break or Detachment Following Cataract Surgery." M. Gilbert Grand, submitted August 5, 2002.
1991-1994	Statistical consultant for multi-center clinical trials, Vision Research Review Committee, NEI
1991	Association for Research in Vision and Ophthalmology (ARVO), Strategic Planning Committee
1992-1997	Chairperson, Scientific Advisory Board, Baltimore Eye Study, Johns Hopkins University, NEI
1993-1999	Chairperson, Scientific Advisory Board, Beaver Dam Eye Study, University of Wisconsin, Madison, NEI
1993-Present	Director, Coordinating Center for Collaborative Longitudinal Evaluation in Keratoconus, NEI
1997-1998	Statistical Consultant for Glaucoma Advisory Panel, National Institutes of Health
2003-2005	National Institute of Neurological Disease and Stroke, Neurological Sciences and Disorders K (NSD-K) Committee
2004-Present	Data and Safety Monitoring Board, Evaluation of a New Outpatient LV Program for Legally Blind Veterans, Veterans Administration Consultant, Ophthalmic Devices Panel of the Medical Devices Advisory Committee, Center for Devices and Radiological Health, FDA
2005-Present	Consultant, Preferred Practice Pattern, Glaucoma Panel Teaching Title and Responsibilities Professor         Division of Biostatistics         Washington University School of Medicine         St. Louis, MO  63110-1093         Professor         Department of Ophthalmology & Visual Sciences         Washington University School of Medicine         St. Louis, MO  63110-1093

BIBLIOGRAPHY

Selected Peer Reviewed Articles (Selected from 91 publications)

1. Kass MA, Meltzer DW, Gordon MO, Cooper D, Goldberg J: Compliance with pilocarpine treatment. Am J Ophthalmol 1986; 101:515-523.
2. Gordon MO, Schechtman KB: Patient compliance: A covariate in randomized clinical trials. Proceedings of the Biopharmaceutical Section of the American Statistical Association, pp. 118-120, 1990.
3. Schechtman KB, Gordon MO: A comprehensive algorithm for determining whether a run-in strategy will be a cost-effective design modification in a randomized clinical trial. Stat Med 1993; 12:111-128.
4. Barr JT, Gordon MO, Zadnik K, Pellican K, Edrington TB, CLEK (Collaborative Longitudinal Evaluation in Keratoconus) Study Group. Photodocumentation of corneal scarring. J Refrac Surg 1996; 12:492-500.
5. Gutierrez P, Wilson MR, Johnson C, Gordon M, Cioffi GA, Ritch R, Sherwood M, Meng K, Mangione CM. Influence of glaucomatous visual field loss on health-related quality of life. Arch Ophthalmol 1997; 115:777-784.
6. Lee BL, Gutierrez P, Gordon M, Wilson RM, Cioffi GA, Ritch R, Sherwood M, Mangione CM: The Glaucoma Symptom Scale: A brief index of glaucoma-specific symptoms. Arch Ophthalmol 1998; 116:861-866.
7. Barr JT, Schechtman KB, Fink BA, Pierce GE, Pensyl CD, Zadnik K, Gordon MO and the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study Group: Corneal scarring in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study: Baseline prevalence and repeatability of detection. Cornea 1999; 18:34-46.
8. Gordon MO, Kass MA and the Ocular Hypertension Treatment Study (OHTS) Group: The Ocular Hypertension Treatment Study: Design and baseline description of the participants. Arch Ophthalmol 1999; 117:573-583.
9. Edrington TB, Szczotka LB, Barr JT, Achtenberg JF, Burger DS, Janoff AM, Olafsson HE, Chun MW, Boyle JW, Gordon MO, Zadnik K, and the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study Group. Rigid contact lens fitting relationships in keratoconus: Current standard of care. Optom Vis Sci 1999; 76:692-699.
10. Zadnik K, Barr JT, Edrington TB, Nichols JJ, Wilson BS, Siegmund K, Gordon MO, the CLEK Study Group. Corneal scarring and vision in Keratoconus: A baseline report from the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study. Cornea 2000; 19:804-812.
11. Brandt JD, Beiser JA, Gordon MO, Kass MA and the OHTS Group. Central corneal thickness in the Ocular Hypertension Treatment Study (OHTS). Ophthalmology 2001:108:1779-1788.
12. Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD; for the National Eye Institute Visual Function Questionnaire Field Test Investigators. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 2001:119:1050-1058.
13. Szczotka LB, Barr JT, Zadnik K, the CLEK Study Group. A summary of the findings from the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study. Optometry 2001;72:574-587.
14. Feuer WJ, Parrish RK, Schiffman JC, Anderson DR, Budenz DL, Wells M-C, Hess DJ, Kass MA, Gordon MO and the OHTS Group. The Ocular Hypertension Treatment Study: Reproducibility of cup/disc ratio measurements over time at an Optic Disc Reading Center. Am J Ophthalmol 2002;133:19-28.
15. Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JK, Miller JP, Parrish, RK, Wilson MR, Gordon MO for the Ocular Hypertension Treatment Study Group. The Ocular Hypertension Treatment Study: A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open angle glaucoma. Arch Ophthalmol 2002; 120:701-713.
16. Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JK, Miller JP, Parrish RK, Wilson MR, Kass MA for the Ocular Hypertension Treatment Study Group. The Ocular Hypertension Treatment Study: Baseline factors that predict the onset of primary open angle glaucoma. Arch Ophthalmol 2002; 120:714-720.
17. Zadnik K, Steger-May K, Fink BA, Joslin CE, Nichols JJ, Rosenstiel CE, Tyler JA, Yu JA, Raasch TW, Schechtman KB for the CLEK Study Group. Between-eye asymmetry in keratoconus. Cornea 2002; 21:671-679.
18. Edrington TB and the CLEK Study Group. What the CLEK Study means to you. The Collaborative Longitudinal Evaluation of Keratoconus Study is providing new insights. Rev Optometry 2002 4/18;61-64. Twenty-sixth Annual Contact Lens Report.
19. Edrington TB, Gundel RE, Libassi DP, Wagner H, Pierce GE, Walline JJ, Barr JT, Olafsson HE, Steger-May K, Achtenberg J, Wilson BS, Gordon MO, Zadnik K, CLEK Study Group. Variables affecting rigid contact lens comfort in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study. Optom Vis Sci 2004;81:182-188.
20. Zangwill LM, Weinreb RN, Berry CC, Smith AR, Dirkes KA, Coleman AL, Piltz-Seymour JR, Liebmann JM, Cioffi GA, Trick G, Brandt JD, Gordon MO, Kass MA for the Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study. Racial differences in optic disc topography: Baseline results from the Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study. Arch Ophthalmol 2004; 122:22-28
21. Zangwill LM, Weinreb RN, Berry CC, Smith AR, Dirkes KA, Liebmann JM, Brandt JD, Trick G, Cioffi GA, Coleman AL, Piltz-Seymour JR, Gordon MO, Kass MA and the Ocular Hypertension Treatment Study (OHTS) Confocal Scanning Laser Ophthalmoscopy (CSLO) Ancillary Study Group. The Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study: Study design and baseline factors. Am J Ophthalmol 2004;137:219-227.
22. Higginbotham EJ, Gordon MO, Beiser JA, Drake MV, Bennett GR, Wilson MR, Kass MA; for the Ocular Hypertension Treatment Study Group. The Ocular Hypertension Treatment Study: Topical medication delays or prevents primary open-angle glaucoma in African American individuals. Arch Ophthalmol 2004;122:824-820.
23. Coleman AL, Gordon MO, Beiser JA, Kass MA for the Ocular Hypertension Treatment Study (OHTS) Group. Baseline risk factors for the development of POAG in the Ocular Hypertension Treatment Study. Am J Ophthalmol. 2004;138(4):684-5.
24. Brandt JD, Beiser JA, Gordon MO, Kass MA and the Ocular Hypertension Treatment Study (OHTS) Group. Central corneal thickness and measured IOP response to topical ocular hypotensive medication. Am J Ophthalmol 2004; 138:717-722.
25. Edrington TB, Gundel RE, Libassi DP, Wagner H, Pierce GE, Walline JJ, Barr JT, Olafsson HE, Steger-May K, Achtenberg J, Wilson BS, Gordon MO, Zadnik K, CLEK Study Group. Variables affecting rigid contact lens comfort in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study. Optom Vis Sci 2004;81:182 -188.
26. Nichols JJ, Steger-May K, Edrington TB, Zadnik K. The relation between disease asymmetry and severity in keratoconus. Br J Ophthalmol 2004; 88:788-791.
27. Kymes SM, Walline JJ, Zadnik K, Gordon MO, Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study Group. (2004) Quality of life in keratoconus. Am J Ophthalmol  2004;138:527-535
28. Kass MA, Gordon MO, Kymes SM for the Ocular Hypertension Treatment Study (OHTS) Group. Incorporating the results of the Ocular Hypertension Treatment Study into clinical practice. Letter to Editor. Arch Ophthalmol 2005;123:1021-1022.
29. Zangwill LM, Weinreb RN, Beiser JA, Berry CC, Cioffi GA, Coleman AL, Trick G, Liebmann JM, Brandt JD, Piltz-Seymour JR, Dirkes KA, Vega S, Kass MA, Gordon MO for the Confocal Scaning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study Group. Baseline topographic optic disc measurements are associated with the development of primary open angle glaucoma: The Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study. Arch Ophthalmol.  2005;123:1188-1197.
30. Barr JT, Wilson BS, Gordon MO, Rah MJ, Riley C, Kollbaum PS, Zadnik K, CLEK Study Group. Estimation of incidence and factors predictive of corneal scarring in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study. Cornea. 2006;25:16-25.